Who founded Aspargo Laboratories?

Aspargo Laboratories was founded by Michael Demurjian in 2019.

How much funding has Aspargo Laboratories raised?

Aspargo Laboratories has disclosed $9.7M raised across 3 rounds.

Where is Aspargo Laboratories headquartered?

Aspargo Laboratories is headquartered in Englewood Cliffs, US.

Aspargo Laboratories

Englewood Cliffs, US · Founded 2019 · Delaware corporation

Aspargo Labs develops and commercializes therapeutic agents, handling drug development and regulatory submissions to agencies including the FDA, EMA, MHRA, PMDA and Swissmedic. Its team draws on the pharmaceutical, biotechnology, and consumer product industries, with operations across Europe (Spain, Germany, UK and Ireland).

Biotech Healthtech Medical Devices

Founders & leadership

Aspargo Laboratories was founded in 2019 by Michael Demurjian.

Michael DemurjianinFounder and CEO of Aspargo Laboratories Inc.

Steven KaplanChief Medical Officer

Mario GuralnikinChief Regulatory Officer

Michael RiceNamed on SEC filing

Fred BiehlNamed on SEC filing

Reported raises · per SEC filings

Form D private placements

$9.7M disclosed across 3 rounds · 2020–2022

▶$290KraisedDec 2022 · Pharmaceuticals

Rule 506(b)

Officers, directors & promoters on the filing

Michael RiceDirector
Fred BiehlDirector
Michael DemurjianExecutive Officer

Offering amount: $15M
Amount sold: $290K
Minimum investment: $40K
Sales commissions: $20.3K
Placement agents: Gene Abrams, Eric Miller
First sale: Nov 2022
Incorporated: Corporation, Delaware, 2019
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$1.5MraisedMar 2022 · 19 investors · Pharmaceuticals

Rule 506(b)

Officers, directors & promoters on the filing

Michael RiceDirector
Michael DemurjianExecutive Officer, Director, Promoter
Fred BiehlDirector

Offering amount: $60M
Amount sold: $1.5M
Minimum investment: $10K
Sales commissions: $91.9K
Placement agents: Newbridge Securities Corporation
First sale: Mar 2022
Incorporated: Corporation, Delaware, 2019
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$7.9MraisedOct 2020 · 290 investors · Pharmaceuticals

Rule 506(b)

Officers, directors & promoters on the filing

Michael RiceDirector
Michael DemurjianExecutive Officer, Director, Promoter
Fred BiehlDirector

Offering amount: $8.5M
Amount sold: $7.9M
Minimum investment: $10K
Sales commissions: $16.7K
Placement agents: David Sukoff, Eagles Coast Capital
First sale: Feb 2020
Incorporated: Corporation, Delaware, 2019
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 1

by search overlap

Walgreens6 shared keywordsWalgreens operates a pharmacy and retail health and wellness business, offering prescription services, over-the-counter medications, health products, and photo services to consumers.

Companies competing with Aspargo Laboratories for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Aspargo Laboratories do?: Aspargo Labs develops and commercializes therapeutic agents, handling drug development and regulatory submissions to agencies including the FDA, EMA, MHRA, PMDA and Swissmedic. Its team draws on the pharmaceutical, biotechnology, and consumer product industries, with operations across Europe (Spain, Germany, UK and Ireland).
Who founded Aspargo Laboratories?: Aspargo Laboratories was founded by Michael Demurjian in 2019.
How much funding has Aspargo Laboratories raised?: Aspargo Laboratories has disclosed $9.7M raised across 3 rounds.
Where is Aspargo Laboratories headquartered?: Aspargo Laboratories is headquartered in Englewood Cliffs, US.